Marvell is buying Lumentum for $115 billion in stock. Here's what shareholders give up, what they get, and whether Marvell ...

Over the past five years, however, the stock is down a mammoth 74%, and C3.ai's recent rally may have more to do with ...

The difference is what else the Vanguard Total Stock Market ETF holds. While the Vanguard S&P 500 ETF sticks exclusively to that index, the Vanguard Total Stock Market ETF covers the entire investable ...

Not Joby Aviation, not Archer Aviation (ACHR-4.11%), but Beta Technologies (BETA-2.53%) gets bragging rights as the first ...

Signed leases worth 270 basis points of future rent are already locked in, setting up built-in revenue growth for next year.

While Nvidia's GPUs excel in just about any situation, Broadcom is taking a different approach to AI computing. It's working directly with AI hyperscalers to design computing units tailored to their ...

At first glance, Alphabet's results were excellent. Revenue jumped 25% year-over-year to $128 billion, giving Alphabet a half ...

Management agreed to sell ITM to lower debt levels and fund core wheel and tire operations. Removing non-core business lines sharpens strategic focus. And it's a clear step toward building long-term ...

Intel's post-earnings slide is an opportunity for investors to buy a potential long-term winner at an attractive valuation.

But that also means we get to reap the rewards of the individual stocks that go on to double, or triple, or even rise five or ...

Viking Therapeutics (VKTX +1.56%) received a new buy rating from UBS on Oct. 14, with analyst Joon Lee assigning the stock a ...

Low-cost workovers and disciplined capital allocation are positioning the company to fund acquisitions rather than chase ...